Epigenetic editing enables safer and more effective T cell therapies
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic editing platform that…
Exercise can mitigate depression-like behaviors induced by high-fat, high-sugar diets
Researchers led by Professor Yvonne Nolan at University College Cork have identified specific metabolic pathways through which exercise…
Women with isolated REM sleep behavior disorder show lesser brain atrophy than men
A large international study involving nearly 700 participants reveals that women with a precursor condition to Parkinson’s disease…
The Bloomberg New Economy Catalyst List 2025
Emily McAteer Co-founder and CEO Odyssey Energy Solutions, US Founded in 2017, Odyssey Energy Solutions operates a digital…
World Record Set For Fastest Genome Sequencing | Health
Key Takeaways Researchers have set a new world record for fastest whole human genome sequencing The team completed…
MRI age clocks reveal how each organ ages differently and predict who develops disease or lives longer
By decoding age gaps across the brain, heart, liver, and more, scientists show that no two organs grow…
After 1- and 6-Month Gains, Gene Editing Companies Await Q3 Results
As developers of gene editing therapies and other genetic medicines get set to report third quarter earnings in…
New insights reveal persistent genome structure during cell division
Before cells can divide, they first need to replicate all of their chromosomes, so that each of the…
NHS issues ‘do not mix’ alert when taking ibuprofen for pain
The NHS has claimed the mixture could lead to a bleeding riskIbuprofen comes in a variety of forms(Image:…
Children with multiple long-term conditions face nearly threefold higher COVID-19 mortality
Individuals with multiple long-term conditions are two and a half times more likely to die following COVID-19 infection…
CogLinks model reveals how the brain adapts to changing rules
Every day, your brain makes thousands of decisions under uncertainty. Most of the time, you guess right. When…
Belzutifan demonstrates strong clinical activity in two rare neuroendocrine tumors
A multicenter Phase II clinical trial led by researchers at The University of Texas MD Anderson Cancer Center…